Skip to menu Skip to content Skip to footer

2009

Journal Article

Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial

Macfarlane, David, Socrates, Angelides, Eisenberg, Paul, Larcos, George, Roach, Paul, Gerometta, Michael, Smart, Richard, Tsui, Wendy and Scott, Andrew M. (2009). Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial. European Journal of Nuclear Medicine and Molecular Imaging, 36 (2), 250-259. doi: 10.1007/s00259-008-0934-7

Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial

2006

Journal Article

Metastatic paraganglioma with extensive bone marrow involvement

Morris, Kirk L., Macfarlane, David, Wyld, David and Kennedy, Glen A. (2006). Metastatic paraganglioma with extensive bone marrow involvement. Asia-Pacific Journal of Clinical Oncology, 2 (4), 193-194. doi: 10.1111/j.1743-7563.2006.00068.x

Metastatic paraganglioma with extensive bone marrow involvement

2006

Journal Article

Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab '

Macfarlane, David J., Smart, Richard C., Tsui, Wendy W., Gerometta, Michael, Eisenberg, Paul R. and Scott, Andrew M. (2006). Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab '. European Journal of Nuclear Medicine and Molecular Imaging, 33 (6), 648-656. doi: 10.1007/s00259-005-0025-y

Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab '

2005

Journal Article

Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a Sm-153-EDTMP-based preparative regimen

Kennedy, G. A., Durrant, S., Butler, J., Morton, J., Western, R., Bartlett, M. L., Allison, R. and MacFarlane, D. J. (2005). Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a Sm-153-EDTMP-based preparative regimen. Leukemia, 19 (5), 879-880. doi: 10.1038/sj.leu.2403698

Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a Sm-153-EDTMP-based preparative regimen

2004

Journal Article

Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

Nieda, M, Okai, M, Tazbirkova, A, Lin, H, Yamaura, A, Ide, K, Abraham, R, Juji, T, Macfarlane, DJ and Nicol, AJ (2004). Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood, 103 (2), 383-389. doi: 10.1182/blood-2003-04-1155

Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

2002

Journal Article

Sm-153 EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies

Macfarlane, DJ, Durrant, S, Bartlett, ML, Allison, R and Morton, AJ (2002). Sm-153 EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies. Nuclear Medicine Communications, 23 (11), 1099-1106. doi: 10.1097/01.mnm.0000040978.43128.ae

Sm-153 EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies

2002

Journal Article

Estimating uptake in liver and abdominal tumours for radionuclide therapy dosimetry

Bartlettt, ML and Macfarlane, DJ (2002). Estimating uptake in liver and abdominal tumours for radionuclide therapy dosimetry. Nuclear Medicine Communications, 23 (8), 743-748. doi: 10.1097/00006231-200208000-00007

Estimating uptake in liver and abdominal tumours for radionuclide therapy dosimetry

2001

Conference Publication

Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.

Durrant, S., Irving, I., Mollee, P., Morton, A. J., Webb, M. and Macfarlane, D. (2001). Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.. 27th Annual Meeting of the European Group for Blood and Marrow Transplantation, London, United Kingdom: Nature Publishing Group.

Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.

1999

Journal Article

Strontium and samarium therapy for bone metastases from prostate carcinoma

Dickie, G. and Macfarlane, D. (1999). Strontium and samarium therapy for bone metastases from prostate carcinoma. Radiation Oncology, 43 (4), 476-479.

Strontium and samarium therapy for bone metastases from prostate carcinoma

1998

Journal Article

Prospective evaluation of 2-[F-18]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma

Macfarlane, DJ, Sondak, V, Johnson, T and Wahl, RL (1998). Prospective evaluation of 2-[F-18]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. Journal of Clinical Oncology, 16 (5), 1770-1776.

Prospective evaluation of 2-[F-18]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma

1998

Conference Publication

Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan phase I experience

Wahl, RL, Zasadny, KR, MacFarlane, D, Francis, IR, Ross, CW, Estes, J, Fisher, S, Regan, D, Kroll, S and Kaminski, MS (1998). Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan phase I experience. Symposium on B1 Therapy in Non-Hodgkins Lymphoma - Dosimetry and Clinical Implications, San Antonio Texas, Jun 01, 1997.

Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan phase I experience

1997

Conference Publication

Venoconstriction is impaired during volume unloading in chronic heart failure

Atherton, J., Thomson, H. L., Macfarlane, D., Fong, W., Moore, T., Wright, K., Muehle, G., Fitzpatrick, L. and Frenneaux, M. (1997). Venoconstriction is impaired during volume unloading in chronic heart failure. 3rd International Congress of Nuclear Cardiology, Florence, Italy, April 1997. Journal of Nuclear Cardiology: Springer. doi: 10.1016/S1071-3581(97)91237-X

Venoconstriction is impaired during volume unloading in chronic heart failure

1996

Journal Article

Successful and unsuccessful approaches to imaging carcinoids: Comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue

Macfarlane, D, Gonin, J, Wielandl, D, Mangner, T, Froelich, J, Beierwaltes, W and Shapirol, B (1996). Successful and unsuccessful approaches to imaging carcinoids: Comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue. European Journal of Nuclear Medicine, 23 (2), 131-140. doi: 10.1007/BF01731835

Successful and unsuccessful approaches to imaging carcinoids: Comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue

1996

Journal Article

Determinants of exercise capacity in patients with coronary artery disease and mild to moderate systolic dysfunction - Role of heart rate and diastolic filling abnormalities

Lele, SS, Macfarlane, D, Morrison, S, Thomson, H, Khafagi, F and Frenneaux, M (1996). Determinants of exercise capacity in patients with coronary artery disease and mild to moderate systolic dysfunction - Role of heart rate and diastolic filling abnormalities. European Heart Journal, 17 (2), 204-212.

Determinants of exercise capacity in patients with coronary artery disease and mild to moderate systolic dysfunction - Role of heart rate and diastolic filling abnormalities

1996

Journal Article

Splenosis in a patient with autoimmune thrombocytopenia

Macfarlane, DJ and Shulkin, B (1996). Splenosis in a patient with autoimmune thrombocytopenia. Clinical Nuclear Medicine, 21 (1), 61-62. doi: 10.1097/00003072-199601000-00015

Splenosis in a patient with autoimmune thrombocytopenia

1995

Journal Article

Intraluminal Hematoma - Another Potential Cause of False-Positive Results with In-Iii Leukocyte Scintigraphy

Macfarlane, DJ and Shulkin, B (1995). Intraluminal Hematoma - Another Potential Cause of False-Positive Results with In-Iii Leukocyte Scintigraphy. Clinical Nuclear Medicine, 20 (12), 1095-1095. doi: 10.1097/00003072-199512000-00016

Intraluminal Hematoma - Another Potential Cause of False-Positive Results with In-Iii Leukocyte Scintigraphy

1995

Journal Article

Fdg Pet Imaging of Paragangliomas of the Neck - Comparison with Mibg Spet

Macfarlane, DJ, Shulkin, BL, Murphy, K and Wolf, GT (1995). Fdg Pet Imaging of Paragangliomas of the Neck - Comparison with Mibg Spet. European Journal of Nuclear Medicine, 22 (11), 1347-1350. doi: 10.1007/BF00801625

Fdg Pet Imaging of Paragangliomas of the Neck - Comparison with Mibg Spet

1995

Journal Article

Spect with 2[fluorine-18]fluoro-2-Deoxy-D-Glucose (fdg) - Reply

Macfarlane, DJ, Cotton, L, Ackermann, RJ, Minn, H, Ficaro, EP, Shreve, PD and Wahl, RL (1995). Spect with 2[fluorine-18]fluoro-2-Deoxy-D-Glucose (fdg) - Reply. Radiology, 197 (2), 343-343.

Spect with 2[fluorine-18]fluoro-2-Deoxy-D-Glucose (fdg) - Reply

1995

Journal Article

Angiosarcomatosis - a Rare Cause of Gastrointestinal-Bleeding Diagnosed by Tc-99m Labeled Red-Cell Spect

Macfarlane, DJ, Khafagi, FA, Gribbin, D, Reinhart, C and Storey, PJ (1995). Angiosarcomatosis - a Rare Cause of Gastrointestinal-Bleeding Diagnosed by Tc-99m Labeled Red-Cell Spect. Clinical Nuclear Medicine, 20 (3), 273-274. doi: 10.1097/00003072-199503000-00020

Angiosarcomatosis - a Rare Cause of Gastrointestinal-Bleeding Diagnosed by Tc-99m Labeled Red-Cell Spect

1995

Journal Article

Triple-Head Spect with 2-[fluorine-18]fluoro-2-Deoxy-D-Glucose (fdg) - Initial Evaluation in Oncology and Comparison with Fdg Pet

Macfarlane, DJ, Cotton, L, Ackermann, RJ, Minn, H, Ficaro, EP, Shreve, PD and Wahl, RL (1995). Triple-Head Spect with 2-[fluorine-18]fluoro-2-Deoxy-D-Glucose (fdg) - Initial Evaluation in Oncology and Comparison with Fdg Pet. Radiology, 194 (2), 425-429.

Triple-Head Spect with 2-[fluorine-18]fluoro-2-Deoxy-D-Glucose (fdg) - Initial Evaluation in Oncology and Comparison with Fdg Pet